These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 7680511)
1. A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards. Nilsson B; Hagström U; Englund A; Säfwenberg J Vox Sang; 1993; 64(1):43-6. PubMed ID: 7680511 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF. Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570 [TBL] [Abstract][Full Text] [Related]
3. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis. Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964 [TBL] [Abstract][Full Text] [Related]
5. [Rapid diagnosis of paroxysmal nocturnal hemoglobinuria by gel test agglutination]. Navenot JM; Bernard D; Petit-Frioux Y; Loirat MJ; Guimbretière J; Muller JY; Blanchard D Rev Fr Transfus Hemobiol; 1993 Apr; 36(2):135-47. PubMed ID: 7684909 [TBL] [Abstract][Full Text] [Related]
6. Decay-accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia. Fujioka S; Yamada T Br J Haematol; 1993 Apr; 83(4):660-2. PubMed ID: 7686037 [TBL] [Abstract][Full Text] [Related]
7. Induction of Fc gamma R-III (CD16) expression on neutrophils affected by paroxysmal nocturnal haemoglobinuria by administration of granulocyte colony-stimulating factor. Ninomiya H; Muraki Y; Shibuya K; Nagasawa T; Abe T Br J Haematol; 1993 Jul; 84(3):497-503. PubMed ID: 7692930 [TBL] [Abstract][Full Text] [Related]
8. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria. Iwamoto N; Kawaguchi T; Nagakura S; Hidaka M; Horikawa K; Kagimoto T; Takatsuki K; Nakakuma H Blood; 1995 Apr; 85(8):2228-32. PubMed ID: 7536494 [TBL] [Abstract][Full Text] [Related]
9. Implication of membrane factors other than DAF and CD59 in complement-mediated lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Hatanaka M; Inai S; Matsumoto M; Miyagawa S; Masaoka T; Kanamaru A; Kawakita M; Yonemura Y; Sugita Y; Seya T Clin Immunol Immunopathol; 1993 Oct; 69(1):52-9. PubMed ID: 7691453 [TBL] [Abstract][Full Text] [Related]
11. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry. Fujioka S; Yamada T Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090 [TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size. Piedras J; López-Karpovitch X Cytometry; 2000 Aug; 42(4):234-8. PubMed ID: 10934342 [TBL] [Abstract][Full Text] [Related]
13. [Paroxysmal nocturnal hemoglobinuria (PNH) deficiency of major complement-regulatory membrane proteins on erythrocytes]. Ninomiya H; Kobayashi T; Abe T Rinsho Ketsueki; 1991 Jun; 32(6):612-7. PubMed ID: 1716325 [TBL] [Abstract][Full Text] [Related]
14. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria. Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703 [TBL] [Abstract][Full Text] [Related]
15. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria. Hillmen P; Hows JM; Luzzatto L Br J Haematol; 1992 Mar; 80(3):399-405. PubMed ID: 1374629 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. Wilcox LA; Ezzell JL; Bernshaw NJ; Parker CJ Blood; 1991 Aug; 78(3):820-9. PubMed ID: 1713516 [TBL] [Abstract][Full Text] [Related]
17. New monoclonal antibodies in CD59: use for the analysis of peripheral blood cells from paroxysmal nocturnal haemoglobinuria (PNH) patients and for the quantitation of CD59 on normal and decay accelerating factor (DAF)-deficient erythrocytes. Fletcher A; Bryant JA; Gardner B; Judson PA; Spring FA; Parsons SF; Mallinson G; Anstee DJ Immunology; 1992 Mar; 75(3):507-12. PubMed ID: 1374058 [TBL] [Abstract][Full Text] [Related]
18. Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype. Hillmen P; Bessler M; Crawford DH; Luzzatto L Blood; 1993 Jan; 81(1):193-9. PubMed ID: 7678064 [TBL] [Abstract][Full Text] [Related]
19. Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes. Meletis J; Terpos E; Samarkos M; Meletis C; Apostolidou E; Komninaka V; Korovesis K; Mavrogianni D; Boutsis D; Variami E; Viniou N; Konstantopoulos K; Loukopoulos D Hematol J; 2001; 2(1):33-7. PubMed ID: 11920231 [TBL] [Abstract][Full Text] [Related]
20. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients. Nagakura S; Nakakuma H; Horikawa K; Hidaka M; Kagimoto T; Kawakita M; Tomita M; Takatsuki K Am J Hematol; 1993 May; 43(1):14-8. PubMed ID: 7686331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]